BAX - Multiplikator P/S Baxter Corp

By diversifying its raw material streams, Baxter International has established an uninterrupted supply of hospital equipment. The company's P/S ratio shows local stabilization, with the metric holding around 1.10. Strict FDA oversight and patent protection create a powerful defensive moat. Management is currently focusing on asset divestiture and debt reduction to restore the investment attractiveness of the core portfolio.

The P/S ratio determines the market value of a business relative to its daily revenue, allowing for an assessment of asset monetization efficiency without the time lags associated with financial reporting. By analyzing the P/S multiple trend, an investor compares market expectations with the expansion rates of Baxter International (BAX), which is increasing sales through the digitalization of patient monitoring and the acquisition of new technological portfolios in the dialysis sector.